Advanced Risk Stratification: Understanding the BSI and FACED Scores
At a Glance
Doctors use risk stratification tools like the Bronchiectasis Severity Index (BSI) and FACED scores to evaluate your lung health. These calculators use factors like age, lung function, and past flare-ups to predict disease severity and guide your personalized preventative treatment plan.
As you and your care team look toward the future, doctors use specialized “calculators” called risk stratification tools to move beyond guesswork. These tools, primarily the Bronchiectasis Severity Index (BSI) and the FACED score, help predict disease severity and guide personalized preventative care [1][2]. They aren’t meant to be “scary” numbers; instead, they help your doctor decide how aggressively to treat your symptoms to prevent future problems [3].
The Bronchiectasis Severity Index (BSI)
The BSI is the most detailed tool available. It uses nine different “ingredients” from your medical history to calculate a total score [1]:
- Age: Risk naturally increases as we get older.
- BMI: Interestingly, having a low Body Mass Index (being underweight) is a risk factor for more severe disease [1].
- FEV1: A measure of how much air you can blow out in one second.
- Hospitalizations: If you were hospitalized for a lung infection in the last year.
- Exacerbations: The number of flare-ups you had in the last year.
- Dyspnea: Your level of shortness of breath (using the mMRC scale).
- Pseudomonas: Whether you are chronically colonized by this specific bacteria [1].
- Other Bacteria: If you have chronic infections with other germs.
- Radiological Extension: How many lobes of your lung show damage on your CT scan [1].
What the Score Means:
- Low (0–4): Low risk of hospitalization or severe flare-ups in the near future.
- Intermediate (5–8): Moderate risk; your doctor may escalate your airway clearance or monitoring.
- High (9+): High risk for frequent hospitalizations [1]. This score often triggers more aggressive preventative treatments, like long-term inhaled antibiotics [4].
The FACED and E-FACED Scores
The FACED score is a simpler, five-point system often used to evaluate overall disease severity [1][5]. It stands for:
- F: FEV1 (Lung function)
- A: Age
- C: Colonization (Pseudomonas)
- E: Extension (Lobes affected on CT)
- D: Dyspnea (Shortness of breath)
Because the original FACED score didn’t account for flare-ups, doctors often use the E-FACED (or Exa-FACED) version. This adds an “E” for Exacerbations—specifically, you get two extra points if you had two or more flare-ups in the last year [6][7]. This makes the tool much better at predicting who might have another “bad stretch” in the near future [8].
The Role of the BACI
While BSI and FACED focus on your lungs, the BACI (Bronchiectasis Aetiology Comorbidity Index) looks at the “rest of you” [9]. It tracks 13 other health conditions—like heart disease or diabetes—that could impact your recovery from a lung infection. When used alongside the BSI, it gives the most complete picture of your overall health outlook [9][10].
Limitations to Keep in Mind
These scores are helpful guides, but they aren’t perfect:
- Population Differences: They may under-predict risk for certain groups, such as those who developed bronchiectasis after tuberculosis or in specific Indigenous populations [11][12].
- Snapshot in Time: These scores represent your health right now. A high score today doesn’t mean you can’t improve; through better airway clearance and treatment, some factors (like exacerbation frequency) can be lowered over time [3].
Common questions in this guide
What is the Bronchiectasis Severity Index (BSI)?
What does a high BSI score mean for my treatment?
How is the FACED score different from the BSI?
Why does my doctor check my BMI for bronchiectasis?
Can my bronchiectasis severity score improve over time?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Can you walk me through my Bronchiectasis Severity Index (BSI) score? Which variables are contributing the most to my risk level?
- 2.Based on my BSI score, what is my statistical risk of being hospitalized for a lung infection in the next year?
- 3.How does my FACED score compare to my BSI? If they tell different stories, which one should we prioritize for my treatment plan?
- 4.Since I've had more than two flare-ups this year, how does that change my E-FACED score and our strategy for preventative therapy?
- 5.Does my BACI (comorbidity) score suggest that my other health conditions are significantly impacting my lung prognosis?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index.
Minov J, Karadzinska-Bislimovska J, Vasilevska K, et al.
The open respiratory medicine journal 2015; (9()):46-51 doi:10.2174/1874306401509010046.
PMID: 25893025 - 2
The bronchiectasis severity index and FACED score for bronchiectasis.
Guan WJ, Chen RC, Zhong NS
The European respiratory journal 2016; (47(2)):382-4 doi:10.1183/13993003.01717-2015.
PMID: 26828048 - 3
Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts.
McDonnell MJ, Aliberti S, Goeminne PC, et al.
Thorax 2016; (71(12)):1110-1118 doi:10.1136/thoraxjnl-2016-208481.
PMID: 27516225 - 4
Prognostic performance of the FACED score and bronchiectasis severity index in bronchiectasis: a systematic review and meta-analysis.
He M, Zhu M, Wang C, et al.
Bioscience reports 2020; (40(10)) doi:10.1042/BSR20194514.
PMID: 33057706 - 5
Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study.
Ellis HC, Cowman S, Fernandes M, et al.
The European respiratory journal 2016; (47(2)):482-9 doi:10.1183/13993003.01312-2015.
PMID: 26585428 - 6
Predicting high risk of exacerbations in bronchiectasis: the E-FACED score.
Martinez-Garcia MA, Athanazio RA, Girón R, et al.
International journal of chronic obstructive pulmonary disease 2017; (12()):275-284 doi:10.2147/COPD.S121943.
PMID: 28182132 - 7
Bronchodilator response as an independent predictor of severity in bronchiectasis.
Kang YR, Lee H, Choi H, et al.
Journal of thoracic disease 2025; (17(10)):7515-7527 doi:10.21037/jtd-2025-713.
PMID: 41229744 - 8
Heterogeneity of non-cystic-fibrosis bronchiectasis in multiethnic Singapore: A prospective cohort study at a tertiary pulmonology centre.
Young SL, Puan Y, Chew SY, et al.
Annals of the Academy of Medicine, Singapore 2021; (50(7)):556-565 doi:10.47102/annals-acadmedsg.202178.
PMID: 34342336 - 9
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.
McDonnell MJ, Aliberti S, Goeminne PC, et al.
The Lancet. Respiratory medicine 2016; (4(12)):969-979 doi:10.1016/S2213-2600(16)30320-4.
PMID: 27864036 - 10
Influence of Comorbidities and Airway Clearance on Mortality and Outcomes of Patients With Severe Bronchiectasis Exacerbations in Taiwan.
Huang HY, Chung FT, Lin CY, et al.
Frontiers in medicine 2021; (8()):812775 doi:10.3389/fmed.2021.812775.
PMID: 35127767 - 11
Utility of Bronchiectasis severity index (BSI) as prognostic tool in patients with post tubercular bronchiectasis: An experience from a tertiary care hospital in North India.
Deshmukh A, Vadala R, Talwar D
The Indian journal of tuberculosis 2021; (68(2)):261-265 doi:10.1016/j.ijtb.2020.09.010.
PMID: 33845962 - 12
Applicability and Validity of the "Bronchiectasis Severity Index" (BSI) and "FACED" Score in Adult Aboriginal Australians.
Howarth T, Gibbs C, Abeyaratne A, Heraganahally SS
International journal of chronic obstructive pulmonary disease 2024; (19()):2611-2628 doi:10.2147/COPD.S482848.
PMID: 39650744
This page explains bronchiectasis severity scores for educational purposes only and does not replace professional medical advice. Always consult your pulmonologist to interpret your specific BSI or FACED results and treatment options.
Get notified when new evidence is published on bronchiectasis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.